WE-CARE Community Health Forums to Increase Breast Cancer Screening and Clinical Trial Participation for Rural and Low Income Women
2026年9月10日 更新者：Mayo Clinic
A Community Engagement Approach to Increasing Breast Cancer Screening and Clinical Trial Participation in Low Income and Rural Populations ('WE-CARE')
This clinical trial tests how well the Women's Engagement for Cancer Awareness, Resources, and Education (WE-CARE) community health forums work to increase breast cancer screening and clinical trial participation for rural and low income women.
Despite advances in breast cancer diagnosis and treatment in the past decade, rural-dwelling and underserved women, and Black, Indigenous, and people of color continue to experience low rates of breast cancer screening.
Since the survival rate for breast cancer is largely dependent on stage at which it is diagnosed, later stage breast cancer is correlated to a poorer prognosis and higher mortality rate.
The WE-CARE community health forms address structural barriers through culturally tailored educational sessions on breast cancer risk, screening and clinical trials, survivor storytelling to humanize cancer and research and patient navigation to facilitate mammogram screening and address barriers.
The WE-CARE community health forums may be an effective way to increase breast cancer screening and clinical trial participation for rural and low income women.
研究概览
研究类型
介入性
注册 (实际的)
1
阶段
- 不适用
联系人和位置
本节提供了进行研究的人员的详细联系信息，以及有关进行该研究的地点的信息。
学习地点
-
-
Wisconsin
-
Eau Claire、Wisconsin、美国、54701
- Mayo Clinic Health System-Eau Claire Clinic
-
-
参与标准
研究人员寻找符合特定描述的人，称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。
资格标准
适合学习的年龄
- 成人
- 年长者
接受健康志愿者
不
描述
Inclusion Criteria:
- Female
- Be between the ages of 50 and 74 years
- Have no prior history of breast cancer screening (i.e., who have either never received a mammogram or have not had one in the past five years)
- Reside in a rural community in Wisconsin or belong to low income (self-reported)
- Be able to speak and understand English or Spanish
- Be willing and able to provide informed consent
Exclusion Criteria:
- Women who have received a mammogram within the past five years
- Have a current or prior diagnosis of breast cancer
- Are currently undergoing treatment for any active malignancy
- Have cognitive or psychiatric impairments that, in the judgment of the study team, would preclude meaningful participation
学习计划
本节提供研究计划的详细信息，包括研究的设计方式和研究的衡量标准。
研究是如何设计的？
设计细节
- 主要用途：卫生服务研究
- 分配：不适用
- 介入模型：单组作业
- 屏蔽：无（打开标签）
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的：Health services research (WE-CARE forum)
Patients attend a WE-CARE community forum, over 2 hours.
At the forum, patients attend educational sessions on breast cancer risk, screening and clinical trials as well as survivor storytelling sessions by community companions who have participated in clinical research for breast cancer.
Patients also receive navigation support to facilitate mammography, address barriers, support scheduling, coordinate follow-up, and provide real-time guidance on screening and matching with clinical trials or registries.
|
Attend education sessions at WE-CARE forum
其他名称：
Receive navigation support
其他名称：
Attend storytelling sessions at WE-CARE forum
其他名称：
|
研究衡量的是什么？
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Recruitment yield
大体时间：At time of forum
|
Assessed via the number enrolled divided by the number of eligible participants approached.
|
At time of forum
|
|
Exposure reach (community level reach)
大体时间：At time of forum
|
Assessed by the number of attendees divided by the estimated number of population indirectly exposed (e.g., via flyers, social media, community announcements).
|
At time of forum
|
|
Retention
大体时间：From baseline to 3 months
|
Assessed by the number of participants who complete 3-month follow-up.
|
From baseline to 3 months
|
|
Perceived participant satisfaction
大体时间：Immediately following completion of forum
|
Success is defined as ≥ 75% of participants rating the experience ≥ 4 on a 5-point scale rated on a 5-point scale where 1=strongly disagree and 5=strongly agree.
Higher scores indicate greater perceived satisfaction.
|
Immediately following completion of forum
|
|
Perceived barriers to engagement and community impact
大体时间：Immediately following completion of forum
|
Assessed by post-intervention focus groups and brief qualitative interviews.
Results will be analyzed descriptively.
|
Immediately following completion of forum
|
|
Perceived facilitators to engagement and community impact
大体时间：Immediately following completion of forum
|
Assessed by post-intervention focus groups and brief qualitative interviews.
Results will be analyzed descriptively.
|
Immediately following completion of forum
|
|
Perceived acceptability - AIM
大体时间：Immediately following completion of forum
|
Assessed using the Acceptability of Intervention Measure (AIM), which consists of 4 items (e.g., meets my approval, is appealing to me) each rated on a 5-point scale where 1=strongly disagree and 5=strongly agree.
Higher scores indicate greater perceived acceptability.
|
Immediately following completion of forum
|
|
Perceived appropriateness - IAM
大体时间：Immediately following completion of forum
|
Assessed using the Intervention Appropriateness Measure (IAM), which consists of 4 items (e.g., seems fitting, seems like a good match) each rated on a 5-point scale where 1=strongly disagree and 5=strongly agree.
|
Immediately following completion of forum
|
|
Perceived feasibility - FIM
大体时间：Immediately following completion of forum
|
Assessed using the Feasibility of Intervention Measure (FIM), which consists of 4 items (e.g., seems implementable, seems easy to use) each rated on a 5-point scale where 1=strongly disagree and 5=strongly agree.
Higher scores indicate greater perceived acceptability.
|
Immediately following completion of forum
|
其他结果措施
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Change in breast cancer screening intention
大体时间：Baseline, 3-month follow-up, 6-month follow-up
|
Assessed using the Risk Behavior Diagnosis Scale (RBDS), which consists of 12 items each rated on a 7-point scale where 1=strongly disagree and 7=strongly agree.
Higher scores reflect greater intention to engage in screening behavior.
|
Baseline, 3-month follow-up, 6-month follow-up
|
|
Chang in breast cancer screening behavior
大体时间：At 6 months post-forum
|
For participants who have never had a mammogram, a follow-up question at six months post-forum will document self-reported mammography completion.
Verification will be optional and used only to evaluate feasibility of data collection.
Results will be analyzed descriptively.
|
At 6 months post-forum
|
|
Perceived trust in medical researchers
大体时间：Baseline, 3-month follow-up, 6-month follow-up
|
Will be assessed using the Trust in Medical Researchers Scale, which consists of 4 items each rated on a 5-point scale where 1=strongly disagree and 5=strongly agree.
higher scores indicating greater perceived trust.
Results will be analyzed descriptively.
|
Baseline, 3-month follow-up, 6-month follow-up
|
|
Change in perceived research readiness
大体时间：Baseline, 3-month follow-up, 6-month follow-up
|
Indicators of research interest will be assessed using descriptively based on subsequent participant enrollment in observational research.
|
Baseline, 3-month follow-up, 6-month follow-up
|
合作者和调查者
在这里您可以找到参与这项研究的人员和组织。
赞助
调查人员
- 首席研究员：Pravesh Sharma, MD、Mayo Clinic Health System-Eau Claire Clinic
出版物和有用的链接
负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。
研究记录日期
这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查，以确保它们在发布到公共网站之前符合特定的质量控制标准。
研究主要日期
学习开始 (实际的)
2026年6月30日
初级完成 (实际的)
2026年9月10日
研究完成 (实际的)
2026年9月10日
研究注册日期
首次提交
2026年6月3日
首先提交符合 QC 标准的
2026年6月8日
首次发布 (实际的)
2026年6月12日
研究记录更新
最后更新发布 (实际的)
2026年9月14日
上次提交的符合 QC 标准的更新
2026年9月10日
最后验证
2026年9月1日
更多信息
此信息直接从 clinicaltrials.gov 网站检索，没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求，请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改，我们的网站上也会自动更新.